Interparfums reports a fall in first-quarter sales

nedimesken

Interparfums on Wednesday reported an 8.5% drop in first-quarter sales, weighed down by global geopolitical tensions and an unfavourable currency effect.

Read More

J&J’s First-Quarter Sales Grow on Cancer-Drug Strength

nedimesken

The drug and medical-device maker has been working to ensure consistent growth after losing patent protection for its blockbuster Stelara.

Read More